期刊
BIOESSAYS
卷 41, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/bies.201800183
关键词
cancer; CDK4; RB; ribosomal proteins; ribosome biogenesis; RPS14; senescence
资金
- FRQS (Fonds de Recherche du Quebec-Sante)
- CRS (Cancer Research Society)
- FRQS
- CIHR (Canadian Institute of Health and Research) [CIHR MOP11151]
- CCSRI (Canadian Cancer Society Research Institute) [704223]
Ribosome biogenesis includes the making and processing of ribosomal RNAs, the biosynthesis of ribosomal proteins from their mRNAs in the cytosol and their transport to the nucleolus to assemble pre-ribosomal particles. Several stresses including cellular senescence reduce nucleolar rRNA synthesis and maturation increasing the availability of ribosome-free ribosomal proteins. Several ribosomal proteins can activate the p53 tumor suppressor pathway but cells without p53 can still arrest their proliferation in response to an imbalance between ribosomal proteins and mature rRNA production. Recent results on senescence-associated ribogenesis defects (SARD) show that the ribosomal protein S14 (RPS14 or uS11) can act as a CDK4/6 inhibitor linking ribosome biogenesis defects to the main engine of cell cycle progression. This work offers new insights into the regulation of the cell cycle and suggests novel avenues to design anticancer drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据